Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A unique association of arrhythmogenic right ventricular dysplasia and acute myocarditis, as assessed by cardiac MRI: a case report

  • Andrea Ponsiglione1Email author,
  • Marta Puglia1,
  • Carmine Morisco1,
  • Luigi Barbuto1,
  • Antonio Rapacciuolo1,
  • Mario Santoro1,
  • Letizia Spinelli1,
  • Bruno Trimarco1,
  • Alberto Cuocolo1 and
  • Massimo Imbriaco1
BMC Cardiovascular DisordersBMC series – open, inclusive and trusted201616:230

https://doi.org/10.1186/s12872-016-0412-2

Received: 8 May 2016

Accepted: 15 November 2016

Published: 21 November 2016

Abstract

Background

Arrhythmogenic right ventricular dysplasia (ARVD), is a genetic disorder of the heart, which mainly involves the right ventricle. It is characterized by hypokinetic areas at the free wall of the right ventricle (RV) or both ventricles, where myocardium is replaced by fibrous or fatty tissue. ARVD is an important cause of ventricular arrhythmias in children and young adults. Although the transmission of the disease is based on hereditary, in young adults it may not show any symptoms. The main differential diagnoses with other frequent etiological causes of sudden arrhythmia are: idiopathic outflow tract ventricular tachycardia of the RV, myocarditis, dilated cardiomyopathy and sarcoidosis.

Case presentation

We describe an unusual case of a 44-year-old woman who was hospitalized for ventricular tachycardia, deep asthenia and dyspnoea with no previous history of cardiac disease. The patient had a ten-year history of palpitations, which started immediately after her last pregnancy. She was diagnosed with both acute/subacute viral myocarditis and arrhythmogenic right ventricular dysplasia, based on established clinical and cardiac MRI criteria. After the diagnosis the patient received an automatic implantable cardioverter defibrillator. Currently, she is on clinical follow-up with no apparent further complications.

Conclusion

Analyzing this rare case, we have shown the link between myocarditis and arrhythmogenic right ventricular dysplasia, and how important is to perform a cardiac MRI, in the context of acute myocarditis and ventricular arrhythmia.

Keywords

Myocarditis Cardiac Magnetic resonance imaging Right ventricle Case report

Background

Arrhythmogenic right ventricular dysplasia (ARVD), is a genetic disorder of the heart, that mainly involves the right ventricle [1, 2]. It is characterized by hypokinetic areas at the free wall of the right ventricle (RV) or both ventricles, where myocardium is replaced by fibrous or fatty tissue. ARVD is an important cause of ventricular arrhythmias in children and young adults. Although the transmission of the disease is based on hereditary, in young adults it may not show any symptoms. The main differential diagnoses with other frequent etiological causes of sudden arrhythmia are: idiopathic outflow tract ventricular tachycardia of the RV, myocarditis [3], dilated cardiomyopathy and sarcoidosis. We hereby describe a rare case of a patient with both acute viral myocarditis and ARVD, as assessed by echocardiography and cardiac MR (CMR).

Case presentation

The patient is a 44 year-old woman with a ten-year history of palpitations, who started immediately after her last pregnancy. She wasn’t an active smoker and had a family history of cardiac disease (her father died at the age of 49 years-old for myocardial infarction). The patient was admitted to the emergency department for palpitations, deep asthenia and dyspnoea appearing suddenly when she was at home, under resting conditions. The patient was not febrile and did not show any episodes of chest pain or syncope. At physical examination, the patient revealed no symptoms of right heart failure. ECG performed at her admission showed a ventricular tachycardia (VT) with heart rate of 192 bpm (Fig. 1). Initially the VT was treated by intravenous bolus of lidocaine. For the resistance of the VT to lidocaine, was injected an intravenous bolus of amiodarone and adenosine. In response to the combined antiarrhythmic treatment, the patient had a drop of systemic blood pressure (80/50 mmHg), developed bradycardia (junctional rhythm at 38 bpm) associated with dizziness. For this reason she was moved to the coronary care unit (CCU). Here she was treated with temporary endocardial pacing and hydration therapy. Within 24 h the patient restored the sinus rhythm and normal blood pressure. ECG recorded in sinus rhythm, showed frequent polymorphic ectopic ventricular beats associated with negative T waves in right precordial leads. On admission in CCU the blood tests revealed an elevated troponin level (23 ng/mL, normal value: <5 ng/mL ng/mL) and an elevated CK-MB level (1240 IU/L, normal value < 120 IU/L). The inflammation markers were also elevated with a C-reactive protein (CRP) of 30,5 mg/L (normal value: < 8 mg/L) and 21.000/mL white blood cells (normal value: 4000-10000/mL). Her plasma electrolyte levels were normal.
Fig. 1

ECG performed on patient admission, showing a ventricular tachycardia with heart rate of 192 bpm

Echocardiography showed a normal geometry of the left ventricle, with a slightly reduced systolic function (EF: 51%), a normal diastolic pattern and mild tricuspid regurgitation; the right ventricle was dilated with evidence of hypokinesia of the apical segment and severely reduced systolic function (TAPSE: 16 mm), hinting the diagnosis of ARVD. CMR was performed using a superconducting system 1.5 T MR (Gyroscan Intera, Philips Medical System, Best, The Netherlands) with a maximum gradient capability of 30 MT/m and maximum slow rate of 150 MT/Ms. MR acquisition was triggered by ECG and included a T1-weighted (T1W) sequence and cine-MR images in the short-axis, and vertical long-axis and horizontal long-axis planes for displaying cardiac contraction. Short time inversion recovery (STIR) T2-weighted (T2W) sequence was obtained to suppress fatty tissue signal. Finally, three-dimensional (3D) T1-delayed enhancement sequences, were acquired at 10, 15 and 20 min, after the intravenous injection of Gd-DTPA at a dose of 0.1 mmol/kg. CMR revealed findings that were consistent with the major criteria of arrhythmogenic right ventricular dysplasia: dilated right ventricle with high end-diastolic volume (EDV) normalized for body surface area (BSA) (116 mL/m2); right ventricular dysfunction with ejection fraction (RVEF) of 18% and regional wall motion abnormalities (diffuse hypokinesia, free wall iper-trabeculation, dyskinesia and mid-RV free wall pseudo-aneurysm) (Fig. 2a and b). On CMR there was a slightly reduced global left ventricular systolic function (EF: 50%) with normal morpho-volumetry of the left ventricle. CMR also revealed the following findings that were consistent with a diagnosis of acute/subacute viral myocarditis: diffuse edema of the right ventricular free wall on STIR images (Fig. 3a and b), associated with sub-epicardial late gadolinium enhancement (Fig. 4a and b) of the same region. Overall, the patient met the criteria for both ARVD and acute/sub acute viral myocarditis. After the diagnosis the patient received an automatic implantable cardioverter defibrillator (AICD) and a beta-blocker (Sotalol) was prescribed at discharge. There was no recurrent VT up to the 4-month follow-up. At 6-month follow-up, the patient complained for palpitation and dizziness. AICD recordings demonstrated 5 sustained VT episodes with appropriate device intervention in all the cases. Transthoracic echocardiography demonstrated a preserved systolic function of the left ventricle (EF: 59%) and a dilated and hypokinetic RV, owing a severely reduced systolic function (TAPSE = 14 mm, fractional change area of 30%). Currently, the patient is on clinical follow-up with no apparent further complications.
Fig. 2

Horizontal long axis (a) and short axis (b) balanced FFE images showing a dilated right ventricle, with diffuse free wall iper-trabeculation and dyskinesia, and mid-RV free wall pseudo-aneurysm. Bilateral pleural effusion is also present; more conspicuous on the right side

Fig. 3

Horizontal long axis (a) and short axis (b) STIR-T2W images showing a diffuse edema of the right ventricular free wall

Fig. 4

Early (a) and delayed (b) dynamic contrast enhanced 3D short axis images, showing abnormal contrast enhancement of the dilated right ventricular free wall

Discussion

ARVD is predominantly a genetically determined heart muscle disorder, pathologically characterized by fibro-fatty replacement of the right ventricular myocardium [1, 2]. This pathology predisposes to ventricular arrhythmias and sudden cardiac death and it can be divided in three progressive phases: in the early “concealed phase” patients are often asymptomatic; in the overt “electrical phase” patients present with symptomatic arrhythmias; finally, in the diffuse disease patients may present with right, left or biventricular heart failure with associated ventricular arrhythmias. Current Task Force Criteria for ARVD diagnosis include, repolarization or depolarization abnormalities on electrocardiography (ECG), presence of ventricular arrhythmias, morphological and functional changes, in addition to histopathology, family history, and genetic findings [2]. Our patient fulfilled the major criteria set by the Task Force [2, 3]: repolarization abnormalities (inverted T waves in right precordial leads in the absence of complete right bundle-branch block), sustained ventricular tachycardia of left bundle-branch morphology with superior axis, RV EDV to BSA ≥ 100 mL/m2 and RVEF ≤ 40%, as assessed by echocardiography and CMR. In addition, the patient fulfilled two of the Lake-Louise criteria for CMR in acute myocarditis [4]. Infact, CMR showed the presence of myocardial edema on STIR-T2W sequences and sub-epicardial necrosis on post-contrast T1W sequences; therefore, these imaging findings added to troponin I and CK-MB release and an elevation of CRP and white blood cells, strongly suggested an acute myocarditis. Several studies have demonstrated that myocarditis may affect the RV, causing structural abnormalities, including microaneurysms, as well as the arrhythmic manifestations that are typical of ARVD. Some cardiotropic viruses (enterovirus or adenovirus), detected in patients with sporadic ARVD, were considered to have a potential role for the disease; in fact the activation of inflammatory mediators, determined by the myocardial infection, could damage the cardiac adherents junctions and the T-tubule system, resulting in ventricular irritability and/or ion channel disruption and consequent ARVD symptomatology [5]. However, this hypothesis is controversial, because the inflammation could be a secondary event; infact, an already diseased myocardium could have an increased susceptibility to viral infection with resulting myocardial inflammation [6]. Therefore, the precise relationship between ARVD and acute myocarditis is not yet determined [7].

In a previous manuscript, Mavrogeni et al. described the case of a patient with Naxos disease, a recessively inherited arrhythmogenic cardiomyopathy (ACM), characterized by woolly hair and palmo-plantar keratoderma [8]. This patient was asymptomatic and presented with chest pain and increased troponin I. A deletion in plakoglobin (cell adhesion protein) gene (Pk2157del2TG) was identified as the cause of Naxos disease [9]; therefore, it has been proposed that a defect in proteins involved in cell–cell adhesion, particularly under mechanical stress conditions, could result in cell death and progressive myocardial fibro-fatty replacement [10]. Moreover, myocardial inflammatory infiltrates, frequently detected in patients with ARVD, have been assumed as a reaction to cell death rather than a consequence of an infective process [11]. As described in recent papers, the reactive nature of myocarditis in ARVD has been supported by the massive inflammatory cell infiltrates found after acute myocardial necrosis in early stages of disease in desmoglein-2 transgenic animal model [12]. In particular, Kant et al. have shown the etiologic role of a deletion of the adhesive extracellular domain of the desmosomal cadherin in mice with an arrhythmogenic right ventricular cardiomyopathy like phenotype, with ventricular dilation and fibrosis. Disturbed sarcomer structure, multiple autophagic vacuoles and swollen mitochondria are typical findings of this cardiomyopathy, inducing cardiomyocyte death, aseptic inflammation and fibrotic replacement, with consequent impairment of the cardiac function [13].

It must be underlined that in our case the patient started to suffer of palpitations and fatigue for light efforts after giving birth her third child in 2009. Therefore, it is reasonable to raise the hypothesis that pregnancy, the hormonal changes and/or inflammatory stress occurring during pregnancy may unmask ARVD. Due to the rarity of cases, the relation between the two events is not yet established. Furthermore, idiopathic right ventricular outflow tract ventricular tachycardia, right ventricular myocardial infarction, dilated cardiomyopathy, myocarditis, pulmonary hypertension, atrial and ventricular septal defects are possible differential diagnoses including a dilated right ventricle. Moreover, sarcoidosis with cardiac involvement can mimic ARVC, making the differential diagnosis very challenging. Uhl’s disease, an unusual cardiac disorder with almost complete absence of right ventricular myocardium, should also be considered as differential diagnosis [14]. ARVD and myocarditis have often different prognosis and treatment; in fact, the former is a complex and progressive entity that requires major clinical intervention, as AICD implantation, or heart transplantation, while the latter is often a self-limited pathology responding to a conservative approach.

To the best of our knowledge, only one case has been published in the English literature showing in a 23 years old man this rare linkage between ARVD and acute myocarditis, based on echocardiography and CMR findings [15]. In agreement with this article, in our case and according to the current international task force consensus statement for ARVD [16] the patient underwent an AICD implantation and is currently in clinical follow up, with no further complications.

In the case presented, CMR allowed the correct identification of the two different clinical entities; in addition, the enhancement pattern as shown on delayed CMR images, may also serve as a map for the exact location of ablation or an endomyocardial biopsy [17].

Conclusions

This case shows the rare association between acute myocarditis and ARVD, highlighting the importance of a complete RV assessment through a CMR study in the context of ventricular arrhythmia. CMR is the most accurate and reproducible technique for assessing the morphology and segmental wall motion of the RV; in addition, it can evaluate the presence of myocardial inflammation with specific STIR-T2W sequences and myocardial fibrosis or necrosis with post-contrast T1W sequences, leading the physician to the correct final diagnosis and to the most appropriate management of patients presenting with ventricular arrhythmias.

Abbreviations

3D: 

Three-dimensional

ACM: 

Arrhythmogenic cardiomyopathy

AICD: 

Automatic implantable cardioverter defibrillator

ARVD: 

Arrhythmogenic right ventricular dysplasia

BSA: 

Body surface area

CCU: 

Coronary care unit

CMR: 

Cardiac MR

CRP: 

C-reactive protein

ECG: 

Electrocardiography

EDV: 

End-diastolic volume

RV: 

Right ventricle

RVEF: 

Right ventricular ejection fraction

STIR: 

Short time inversion recovery

T1W: 

T1-weighted

T2W: 

T2-weighted

VT: 

Ventricular tachycardia

Declarations

Acknowledgements

Gennaro Fraia and Fabio Garbino (Technologists) for their contribution in making this study possible.

Funding

Not applicable.

Availability of data and materials

data regarding this manuscript are available at the Department of Advanced Biomedical Sciences, at the University Federico II, Naples, Italy; Via Pansini 5.

Authors’ contributions

MI, MP, AP, AC and BT: Study design and conception, Cardiac MR interpretation and manuscript preparation; CM, MS, LS and AR: acquisition of data, coronary care unit, drafting the manuscript; LB, MP, AP and MI: acquisition of cardiac MR data and interpretation of images. AC and BT: manuscript critical revision. All authors read and approved the final manuscript.

Authors’ information

All authors belong to the Department of Advanced Biomedical Sciences, University “Federico II”, Via Pansini 5, 80123, Naples, Italy.

Competing interests

Not applicable.

Consent for publication

The patient gave written informed consent to publish this manuscript.

Ethics approval and consent to participate

This case report was approved by the local institutional review board and the patient gave written informed consent to partecipate for this manuscript.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Advanced Biomedical Sciences, University “Federico II”

References

  1. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289–300.View ArticlePubMedGoogle Scholar
  2. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31:806–14.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 2010;121:1533–41.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53:1475–87.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Bowles NE, Ni J, Marcus F, Towbin JA. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2002;39:892–5.View ArticlePubMedGoogle Scholar
  6. Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol. 2004;43:2305–13.View ArticlePubMedGoogle Scholar
  7. Jordan AN, Lyne J, De Silva R, Wong T. Myocarditic appearance of arrhythmogenic right ventricular cardiomyopathy. Circulation. 2010;122:e556–7.View ArticlePubMedGoogle Scholar
  8. Mavrogeni S, Protonotarios N, Tsatsopoulou A, Papachristou P, Sfendouraki E, Papadopoulos G. Naxos disease evolution mimicking acute myocarditis: The role of cardiovascular magnetic resonance imaging. Int J Cardiol. 2013;166(1):e14–5. doi:https://doi.org/10.1016/j.ijcard.2012.12.078.View ArticlePubMedGoogle Scholar
  9. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet. 2000;355:2119–24.View ArticlePubMedGoogle Scholar
  10. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009;360:1075–84.View ArticlePubMedGoogle Scholar
  11. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation. 1996;94:983–91.View ArticlePubMedGoogle Scholar
  12. Pilichou K, Remme CA, Basso C, Campian ME, Rizzo S, Barnett P, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 2009;206:1787–802.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Kant S, Krull P, Eisner S, Leube RE, Krusche CA. Histological and ultrastructural abnormalities in murine desmoglein 2-mutant hearts. Cell Tissue Res. 2012;348:249–59. doi:https://doi.org/10.1007/s00441-011-1322-3.View ArticlePubMedGoogle Scholar
  14. Haugaa KH, Haland TF, Leren IS, Saberniak J, Edvardsen T. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis. Europace. 2015. doi:https://doi.org/10.1093/europace/euv340.PubMedGoogle Scholar
  15. Huttin O, Frikha Z, Brembilla-Perrot B, Sellal JM, Mandry D, Aliot E, et al. Acute myocarditis presenting with ventricular arrhythmias: the role of CMR in the differential diagnosis of ARVD. Intern Med. 2013;52:1915–8.View ArticlePubMedGoogle Scholar
  16. Corrado D, Wichter T, Link MS, Hauer R, Marchlinski F, Anastasakis A. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36:3227–37.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Tavano A, Maurel B, Gaubert JY, Varoquaux A, Cassagneau P, Vidal V, et al. MR imaging of arrhythmogenic right ventricular dysplasia: What the radiologist needs to know. Diagn Interv Imaging. 2015;96:449–60.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016